Radical Wide Local Resection in Vulvar Cancer

  • Alejandro Soderini
  • Alejandro Aragona
Chapter

Abstract

Carcinoma of the vulva accounts for approximately 4–5% of all the cases of gynecologic malignancies [1–7]. It is estimated that about 27,000 cases are diagnosed each year around the world.

Keywords

vulvar cancer radical wide vulvar resection 

Notes

Acknowledgments

To Nick Reed and Nicasio Cuneo

References

  1. 1.
    Benedet JL, Bender H, Jones H 3rd, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000;70:209–62.PubMedCrossRefGoogle Scholar
  2. 2.
    Guixa-Otturi-Guixa. Cap. Patología vulvar. Compendio de Ginecología para alumnos. Quinta Edición. Lopez Libreros Editores. Buenos Aires; 1985. p. 395–404.Google Scholar
  3. 3.
    Ávila M, Castro G. Patología de la vulva y vagina. Provenzano-Lange-Tatti; Manual de Ginecología. Cap.26. Primera Edición. Editorial Corpus. Buenos Aires, 2006; p. 291–302.Google Scholar
  4. 4.
    Maldonado M, Susuki V. Patología de la vulva y vagina. Provenzano-Lange-Tatti; Manual de Ginecología. Segunda edición. Cap. 27. Editorial Corpus. Buenos Aires; 2014. p. 411–422.Google Scholar
  5. 5.
    Asociación Argentina de Ginecología Oncológica. Cáncer de Vulva. Guías para el diagnóstico, tratamiento y seguimiento del Cáncer ginecológico. Editorial Ascune. Buenos Aires; 2016. p. 129–149.Google Scholar
  6. 6.
    Levine D, De los Santos J, Fleming G, Barakat R, Markman M, Randall M. The vulva. Handbook for principles and practice of gynecologic oncology. Philadelphia: Lippicott Williams & Wilkins; 2010. 95–96.Google Scholar
  7. 7.
    Aragona AM, Cúneo N, Soderini AH, Alcoba E, Greco A, Reyes C, Lekmann S. Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: Neoadjuvant chemotherapy followed by radical surgery. Results from a multicenter study. Int J Gynecol Cancer. 2012;22(7):1258–63.PubMedCrossRefGoogle Scholar
  8. 8.
    Judson PL, Habermann EB, Baxter NN, et al. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107:1018.PubMedCrossRefGoogle Scholar
  9. 9.
    Alkatout I, Schubert M, Garbrecht N, Weigel MT, Jonat W, Mundhenke C, Günther V. Vulvar cancer: epidemiology, clinical presentation, and management options. Int J Womens Health. 2015;7:305–13.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2006;56:106–30.PubMedCrossRefGoogle Scholar
  11. 11.
    Stroup AM, Harlan LC, Trimble EL. Demographic, clinical and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol. 2008;108:577–83.PubMedCrossRefGoogle Scholar
  12. 12.
    Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.PubMedCrossRefGoogle Scholar
  13. 13.
    Sobin LH, Gospodarowicz MK, Wittekind CH, editors. TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2009.Google Scholar
  14. 14.
    Aragona AM, Soderini AH, Cuneo NA. Defining the concept of locally advanced squamous cell carcinoma of the vulva: a new perspective based on standardization of criteria and current evidence. J Gynecol Oncol. 2014;25(4):272–8.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Aragona AM, Cuneo NA, Soderini AH, Alcoba EB. An analysis of reported independent prognostic factors for survival in squamous cell carcinoma of the vulva: is tumor size significance being underrated? Gynecol Oncol. 2014;132(3):643–8.PubMedCrossRefGoogle Scholar
  16. 16.
    De Hullu JA, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MP, et al. Vulvar carcinoma. The price of less radical surgery. Cancer. 1992;95(11):2331–8.CrossRefGoogle Scholar
  17. 17.
    Chan JK, Sugiyama V, Pham H, Gu M, Rutgers J, Osann K, et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol. 2007;104:636–41.PubMedCrossRefGoogle Scholar
  18. 18.
    Baiocchi G, Rocha RM. Vulvar cancer surgery. Curr Opin Obstet Gynecol. 2014;26(1):9–17.PubMedCrossRefGoogle Scholar
  19. 19.
    Micheletti L, Preti M. Surgery of the vulva in vulvar cancer. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):1074–87.PubMedCrossRefGoogle Scholar
  20. 20.
    Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42(1):79–85.PubMedCrossRefGoogle Scholar
  21. 21.
    Itala J, Belardi G, Sardi J, et al. Poliquimioterapia neoadyuvante en el tratamiento del carcinoma invasor de la vulva. Rev Soc Obstet Ginecol B Aires. 1986;865:239–45.Google Scholar
  22. 22.
    Shimizu Y, Hasumi K, Masubuchi K. Effective chemotherapy consisting of bleomycin, vincristine, mitomycin C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer. Gynecol Oncol. 1990;36:423–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Domingues AP, Mota F, Durao M, et al. Neoadjuvant chemotherapy in advanced vulvar cancer. Int J Gynecol Cancer. 2010;20:294–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Raspagliesi F, Zanaboni F, Martinelli F, casso S, Laufer J, Ditto A. Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva. J Gynecol Oncol. 2014;25(1):22–9.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Benedetti-Panici P, Greggi S, Scambia G, et al. Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma. Gynecol Oncol. 1993;50:49–53.PubMedCrossRefGoogle Scholar
  26. 26.
    Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol. 2006;100:53–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Sardi JE, Giaroli A, Sananes C, Di Paola GR. A possible new trend in the management of the carcinoma of the cervix uteri. Gyn Oncol. 1986;25:139.CrossRefGoogle Scholar
  28. 28.
    Sardi J, Giaroli A, Sananes C, Ferreira M, Soderini A, Bermudez A, Snaidas L, Vighi S, Gomez Rueda N, di Paola G. Long term follow up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol. Oncologia. 1997;67:61–9.Google Scholar
  29. 29.
    Sananes C, Giaroli A, Soderini A, Guardado N, Sanaidas L, Bermúdez A, Ferreira M, Di Paola G, Sardi J. Neoadjuvant chemotherapy followed by radical hysterectomy and postoperative adjuvant chemotherapy in the treatment of carcinoma of the cérvix uteri: long-term follow up of a pilot study. Eur J Gynaecol Oncol. 1998;19(4):368–73.PubMedGoogle Scholar
  30. 30.
    Tierney J. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration. Eur J Cancer. 2003;39(17):2470–86. Review.CrossRefGoogle Scholar
  31. 31.
    Soderini A, Aragona A, Reed N. Advanced vulvar cancers: what are the best options for treatment? Curr Oncol Rep. 2016;18(9); accepted. “In Press”.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Alejandro Soderini
    • 1
    • 2
  • Alejandro Aragona
    • 1
    • 2
  1. 1.University of Buenos AiresBuenos AiresArgentina
  2. 2.Oncologic Hospital of Buenos Aires “ Marie Curie”Buenos AiresArgentina

Personalised recommendations